Biosimilars Council urges House to pass patent thicket legislationS. 150 passed the Senate and was placed on the House of Representatives' suspension calendar. Body, heal thyselfA focus on wellness, personalized treatments and clean ingredients has fueled interest in homeopathic products. FDA approves Roche’s Ocrevus Zunovo with Halozyme’s Enhanze drug delivery technology Ocrevus Zunovo with Halozyme's Enhanze drug delivery technology is used for the treatment of relapsing multiple sclerosis and primary progressive multiple sclerosis. Chasing health inclusivity The industry is tackling pharmacy-access inequities with a variety of strategies. Alembic intros acitretin capsules Acitretin capsules are indicated for the treatment of severe psoriasis in adults. Alembic intros fluphenazine hydrochloride tablets Fluphenazine hydrochloride tablets are are indicated in the management of manifestations of psychotic disorders. Johnson & Johnson obtains FDA OK for new indication for Tremfya Tremfya is now approved for the treatment of plaque psoriasis, active psoriatic arthritis and ulcerative colitis. AAM, Biosimilars Council releases statement on statement on Senate Judiciary Markup of PREVAIL and PERA The Association for Accessible Medicines and its Biosimilars Council oppose passage of the PREVAIL Act and the PERA Act. Kourtney Kardashian Barker’s Lemme rolls out GLP-1 supplement The supplement does not contain synthetic GLP-1 hormone and is not a GLP-1 agonist drug, the company said. Sponsored Dr. Florencia Ziemke talks GLP-1-related nausea, Sea Band as a potential solution The doctor has been using and observing the effectiveness of the Sea Band nausea-relief device in her practice. First Previous 13 14 15 16 17 Next Last
